Literature DB >> 19629380

Screening for colorectal cancer using a quantitative immunochemical faecal occult blood test: a feasibility study in an Asian population.

W-P Fu1, M-H Kam, W-M Ling, S-F Ong, N Suzannah, Kong-Weng Eu.   

Abstract

BACKGROUND: The quantitative immunochemical faecal occult blood test (qFOBT) has been shown to be an accurate method of identifying significant colorectal neoplasia including cancer and advanced adenomas. This study reports the results of a Singapore population-based colorectal cancer screening event using the qFOBT.
METHODS: This event was held as part of a colorectal cancer awareness exhibition. All asymptomatic individuals above the age of 40 years with no previous colorectal cancer screening in the last 1 year were invited to participate. Eligible participants were screened using two consecutive qFOBTs with a positive faecal haemoglobin threshold taken at 100 ng/mL. Participants with at least one positive qFOBT result were recalled and advised to undergo colonoscopy. Endoscopic polypectomy or surgery was performed according to colonoscopic findings.
RESULTS: A total of 751 (55% male, 45% female) participants with a median age of 53 years (range, 40-85 years) took part in the screening event. Five hundred and forty (72%) participants returned the qFOBT samples, of which 57 (11%) tested positive. Fifty-two of these participants proceeded to colonoscopy. Three participants had sigmoid cancer and 12 had advanced polyps, all of which were located distally in the sigmoid colon or rectum. Five of the participants required surgery for colorectal neoplasia and all recovered well without complications.
CONCLUSION: The qFOBT at a positive faecal haemoglobin threshold of 100 ng/ml has a high positive predictive value and is an effective screening tool for colorectal cancer in an Asian population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19629380     DOI: 10.1007/s10151-009-0515-1

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  17 in total

1.  A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.

Authors:  Tamiya Morikawa; Jun Kato; Yutaka Yamaji; Ryoichi Wada; Toru Mitsushima; Yasushi Shiratori
Journal:  Gastroenterology       Date:  2005-08       Impact factor: 22.682

2.  Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.

Authors:  Alex Vilkin; Paul Rozen; Zohar Levi; Amal Waked; Eran Maoz; Shlomo Birkenfeld; Yaron Niv
Journal:  Am J Gastroenterol       Date:  2005-11       Impact factor: 10.864

3.  A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy.

Authors:  P D Greenberg; L Bertario; R Gnauck; O Kronborg; J D Hardcastle; M S Epstein; D Sadowski; R Sudduth; G R Zuckerman; D C Rockey
Journal:  Am J Gastroenterol       Date:  2000-05       Impact factor: 10.864

4.  A quantitative immunochemical fecal occult blood test for colorectal neoplasia.

Authors:  Zohar Levi; Paul Rozen; Rachel Hazazi; Alex Vilkin; Amal Waked; Eran Maoz; Shlomo Birkenfeld; Moshe Leshno; Yaron Niv
Journal:  Ann Intern Med       Date:  2007-02-20       Impact factor: 25.391

5.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.

Authors:  J D Hardcastle; J O Chamberlain; M H Robinson; S M Moss; S S Amar; T W Balfour; P D James; C M Mangham
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

6.  Randomised study of screening for colorectal cancer with faecal-occult-blood test.

Authors:  O Kronborg; C Fenger; J Olsen; O D Jørgensen; O Søndergaard
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

7.  Evaluation of an automated immunochemical fecal occult blood test for colorectal neoplasia detection in a Chinese population.

Authors:  Wai Man Wong; Shiu Kum Lam; Kwan Lok Cheung; Teresa Sze Man Tong; Paul Rozen; Graeme P Young; Kin Wah Chu; Judy Ho; Wai Lun Law; Hiu Ming Tung; Hok Kwok Choi; Yee Man Lee; Kam Chuen Lai; Wayne H C Hu; Chi Kuen Chan; Man Fung Yuen; Benjamin Chun-Yu Wong
Journal:  Cancer       Date:  2003-05-15       Impact factor: 6.860

Review 8.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.

Authors:  Bernard Levin; David A Lieberman; Beth McFarland; Kimberly S Andrews; Durado Brooks; John Bond; Chiranjeev Dash; Francis M Giardiello; Seth Glick; David Johnson; C Daniel Johnson; Theodore R Levin; Perry J Pickhardt; Douglas K Rex; Robert A Smith; Alan Thorson; Sidney J Winawer
Journal:  Gastroenterology       Date:  2008-02-08       Impact factor: 22.682

9.  Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.

Authors:  James E Allison; Lori C Sakoda; Theodore R Levin; Jo P Tucker; Irene S Tekawa; Thomas Cuff; Mary Pat Pauly; Lyle Shlager; Albert M Palitz; Wei K Zhao; J Sanford Schwartz; David F Ransohoff; Joseph V Selby
Journal:  J Natl Cancer Inst       Date:  2007-09-25       Impact factor: 13.506

10.  Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programme.

Authors:  S Ciatto; F Martinelli; G Castiglione; P Mantellini; T Rubeca; G Grazzini; A G Bonanomi; M Confortini; M Zappa
Journal:  Br J Cancer       Date:  2007-01-09       Impact factor: 7.640

View more
  1 in total

1.  Findings from the first colorectal cancer screening among 103 542 individuals in Vietnam with systematic review of colorectal cancer screening programs in Asia-Pacific region.

Authors:  Chi Thi-Du Tran; Mai Vu-Tuyet Nguyen; Mo Thi Tran; Thuy Thi-Van Tuong; Quang Hong Tran; Linh Cu Le; Huong Thi-Thu Pham; Nam Chi Bui; Hien Huy Vu; Tu Thi-Cam Nguyen; Phuong Que Ta; Hien Thi-Thu Ha; Dung Tuan Trinh; Hanh Thi-My Bui; Dien Quang Trinh; Khanh Van Nguyen; Song Huu Le; Khien Van Vu; Thuan Van Tran; Huong Thi-Thanh Tran; Martha J Shrubsole; Fei Ye; Qiuyin Cai; Wei Zheng; Paolo Boffetta; Xiao-Ou Shu; Hung N Luu
Journal:  Jpn J Clin Oncol       Date:  2022-07-08       Impact factor: 2.925

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.